Skip to main content

Table 1 The bacteria and the antibiotics we used

From: Antibiotic treatment regimens for bone infection after debridement: a study of 902 cases

Bacteria

Intravenous antibiotics

Oral antibiotics

Adults

Pediatrics

Adults

Pediatrics

MSSA/MSSE

Cefazolin:2 g q8h. Cefuroxime:1.5 g q8h. Ceftriaxone:2 g q12h. Levofloxacin:600 mg qd, Moxifloxacin:400 mg qd

Cefazolin:50-100 mg/(kg.d) q8h. Cefuroxime: 30-100 mg/(kg.d) q8h. Ceftriaxone:20-80 mg/(kg.d) qd

Levofloxacin:500 mg qd, Moxifloxacin:400 mg qd) .

Cefuroxime:500 mg bid

Cefuroxime: 10 mg/Kg, bid

MRSA/MRSE

Vancomycin:15~20 mg/Kg q8~12h. Linezolid:600 mg q12h

Vancomycin:40 mg/(kg.d) 2 to 4 times/d. Linezolid: 10 mg/kg q8h

Linezolid:600 mg q12h. Fluoroquinolone.

Linezolid: 10 mg/kg q8h

P.aeruginosa/E.coli/E.cloaca/K. pneumoniae

Ceftazidime:2 g q8h/Cefepime:2 g q12h/PiperacillinTazobactam:4.5 g q8h /Levofloxacin;500 mg qd/Amikacin:15 mg/Kg qd (usually used in combination)

Ceftazidime:30-100 mg/(kg.d) q8h.

Cefepime:40 mg/Kg q12h.

PiperacillinTazobactam:112.5 mg/Kg q8h

Levofloxacin: 500 mg qd

No oral

Others

According to drug sensitivity

According to drug sensitivity

According to drug sensitivity

According to drug sensitivity

Negative

Ceftazidime / Cefepime / Fluoroquinolone

Ceftriaxone 20-80 mg/(kg.d) qd

Fluoroquinolone

Cefuroxime: 10 mg/Kg, bid

  1. MSSA/MSSE: Methicillin-susceptible Staphylococcus aureus/ epidermidis. The dosage is suitable for patients with no serious liver and renal dysfunction